NovaBay Pharmaceuticals Inc (NBY) earnings · $51.9M cap
These earnings events as JSON? API free 100/dayNovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
This NBY earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NBY revenue for 2026-06-30 was $2.2M. Net income was -$41.1M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. NBY currently screens at market cap $51.9M.
When the next NBY 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 10.4% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full NBY research stays on the stock page; the tape stays on the quote page.
NBY earnings FAQ
What are NBY's latest revenue and net income?
Latest cached NovaBay Pharmaceuticals Inc (NBY) revenue for Jun 30, 2026 was $2.2M. Net income was -$41.1M. Statements: https://lician.com/financials/nby
What is NBY's latest diluted EPS?
Latest cached NovaBay Pharmaceuticals Inc (NBY) diluted EPS for Jun 30, 2026 was -$1.32.
What period does the latest NBY earnings print cover?
The latest cached NovaBay Pharmaceuticals Inc (NBY) earnings print covers Jun 30, 2026. The prior cached period on this page is Mar 31, 2026.
How did NBY revenue change from the prior cached period?
Cached NovaBay Pharmaceuticals Inc (NBY) revenue was down 10.4% from $2.5M (Mar 31, 2026) to $2.2M (Jun 30, 2026). Statements: https://lician.com/financials/nby
Where are NBY earnings listed?
Cached earnings facts for NovaBay Pharmaceuticals Inc (NBY) are listed at https://lician.com/earnings/nby. Statements: https://lician.com/financials/nby
Not investment advice.